Harrow, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Harrow, Inc. (HROW) had Stockholders' Equity Attributable to Noncontrolling Interest of -$355.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2026-08-10
- 2026-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$355.00K.
- 2026-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$355.00K.
- 2025-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$355.00K.
- 2025-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$355.00K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | -$355.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$355.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | -$355.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | -$355.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$355.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$355.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$355.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | -$355.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | -$355.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$355.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$355.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$355.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$355.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$355.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$355.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | -$355.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$355.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$355.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$355.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | -$355.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$355.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | -$355.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$355.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | -$347.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$332.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | -$309.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$293.00K 10-K · filed 2021-03-08 |
| 2019-09-30 | -$228.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$67.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$25.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |